Using in Vivo Confocal Microscope to Evaluate the Corneal Wound Healing After Various Ocular Surgeries

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00491439
Collaborator
(none)
120
1
41
2.9

Study Details

Study Description

Brief Summary

Although epi-keratome laser-assisted in situ keratomileusis (Epi-LASIK), penetrating keratoplasty and pars plana vitrectomy with corneal epithelial debridement for diabetic retinopathy are surgeries commonly performed, the time-sequential, in vivo microscopic wound healing process is not fully understood. The purpose of this study is to study the healing of corneal wounds after Epi-LASIK, penetrating keratoplasty and pars plana vitrectomy with corneal epithelial debridement for diabetic retinopathy by in vivo confocal microscopy, an easily performed and non-invasive procedure. We plan to enroll 40 eyes of 40 patients in each of these three surgeries. In Epi-LASIK, slit-lamp biomicroscopy, in vivo confocal microscopy, and visual acuity are recorded before and 1, 3, and 7 days after surgery. The eyes are examined weekly in the first month and at 3 and 6 months. For penetrating keratoplasty and pars plana vitrectomy with corneal epithelial debridement, slit-lamp biomicroscopy, in vivo confocal microscopy, and visual acuity are recorded before and weekly in the first month after surgeries and at 3 and 6 months. Selected images of the corneal basal/apical surface epithelia, stromal reactions and corneal endothelial conditions by in vivo confocal microscopy are evaluated qualitatively for the cellular morphology and density.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Although epi-keratome laser-assisted in situ keratomileusis (Epi-LASIK), penetrating keratoplasty and pars plana vitrectomy with corneal epithelial debridement for diabetic retinopathy are surgeries commonly performed, the time-sequential, in vivo microscopic wound healing process is not fully understood. The purpose of this study is to study the healing of corneal wounds after Epi-LASIK, penetrating keratoplasty and pars plana vitrectomy with corneal epithelial debridement for diabetic retinopathy by in vivo confocal microscopy, an easily performed and non-invasive procedure. We plan to enroll 40 eyes of 40 patients in each of these three surgeries. In Epi-LASIK, slit-lamp biomicroscopy, in vivo confocal microscopy, and visual acuity are recorded before and 1, 3, and 7 days after surgery. The eyes are examined weekly in the first month and at 3 and 6 months. For penetrating keratoplasty and pars plana vitrectomy with corneal epithelial debridement, slit-lamp biomicroscopy, in vivo confocal microscopy, and visual acuity are recorded before and weekly in the first month after surgeries and at 3 and 6 months. Selected images of the corneal basal/apical surface epithelia, stromal reactions and corneal endothelial conditions by in vivo confocal microscopy are evaluated qualitatively for the cellular morphology and density.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    120 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Phase 1 Study of in Vivo Confocal Microscope to Evaluate the Corneal Wound Healing After Various Ocular Surgeries
    Study Start Date :
    Apr 1, 2007
    Actual Study Completion Date :
    Sep 1, 2010

    Arms and Interventions

    Arm Intervention/Treatment
    Corneal wounds after Epi-LASIK

    Corneal wounds after Epi-LASIK

    penetrating keratoplasty

    Corneal wound after penetrating keratoplasty

    corneal epithelial debridement

    Corneal wound after pars plana vitrectioy with corneal epithelial debridement for diabetic retinopathy

    Outcome Measures

    Primary Outcome Measures

    1. cellular morphology and density [before surgery and 1, 3, and 7 days after surgeryfirst month and at 3 and 6 months]

    Secondary Outcome Measures

    1. corneal basal/apical surface epithelia, stromal reactions and corneal endothelial conditions [before and 1, 3, and 7 days after surgery, first month and at 3 and 6 months]

    2. visual acuity [before and 1, 3, and 7 days after surgery, first month and at 3 and 6 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • patients receiving various ocular surgeries

    • no previous ocular surgery

    • tear break up time longer than 10 seconds

    • Shirmer test II larger than 5 mm

    • no presurgical corneal disease confirmed by slit lamp and in vivo confocal

    • no limbus defect

    • proliferative retinopathy underwent vitrectomy combining corneal epithelial scrating

    Exclusion Criteria:
    • can not complete follow up

    • ineligible for ocular surgery

    • eyelid closure incomplete

    • glaucoma

    • corneal defect or oculoneuropathy not caused by diabetes

    • severe dry eye disease

    • limbus defect

    • pregnant

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Wei-Li Chen Taipei Taiwan

    Sponsors and Collaborators

    • National Taiwan University Hospital

    Investigators

    • Principal Investigator: Fung-Rong Hu, MD, Department of Ophthalmology, National Taiwan Universtiy Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    National Taiwan University Hospital, Wei-Li Chen/Associate Professor, National Taiwan University Hospital
    ClinicalTrials.gov Identifier:
    NCT00491439
    Other Study ID Numbers:
    • 200702038R
    First Posted:
    Jun 26, 2007
    Last Update Posted:
    Apr 3, 2012
    Last Verified:
    Nov 1, 2010
    Keywords provided by National Taiwan University Hospital, Wei-Li Chen/Associate Professor, National Taiwan University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 3, 2012